Understanding Extrapyramidal Side-Effects of Antipsychotic Medications

One common extrapyramidal side-effect of antipsychotic medications is akathisia, which is characterized by a subjective feeling of restlessness and an inability to sit still. This is often seen in the legs and can be caused by first-generation typical antipsychotics like flupentixol. Treatment involves reducing or switching the medication dose.

Neuroleptic malignant syndrome is another potential side-effect that occurs within days of starting antipsychotic medication. It presents with symptoms such as pyrexia, muscle rigidity, autonomic lability, and confusion. Rapid diagnosis and treatment with fluids, cooling, benzodiazepines, and dantrolene are necessary.

Acute dystonic reactions, such as torticollis, oculogyric crises, and trismus, can occur within hours to days of taking antipsychotic medications. These extrapyramidal side-effects are more common in first-generation typical antipsychotics due to their increased anti-dopaminergic activity. Treatment may involve anticholinergic drugs like procyclidine.

Parkinsonism refers to features associated with antipsychotic medication that are essentially the same as iatrogenic Parkinsonism, including joint rigidity, bradykinesia, and tremor. These symptoms are more common in first-generation typical antipsychotics.

Finally, tardive dyskinesia is a late-onset movement disorder that can occur after long-term use of antipsychotics. It presents with involuntary movements such as lip-smacking and grimacing. While this patient may have been on flupentixol for a long time, they do not present with these symptoms.

Fabricating or inflating symptoms for financial benefit is known as malingering, such as an individual who feigns whiplash following a car accident in order to receive an insurance payout.

This can be challenging as the individual may be experiencing withdrawal symptoms from opioid abuse. Nevertheless, among the given choices, the most suitable term to describe the situation is malingering since the individual is intentionally reporting symptoms to obtain morphine.

Psychiatric Terms for Unexplained Symptoms

There are various psychiatric terms used to describe patients who exhibit symptoms for which no organic cause can be found. One such disorder is somatisation disorder, which involves the presence of multiple physical symptoms for at least two years, and the patient’s refusal to accept reassurance or negative test results. Another disorder is illness anxiety disorder, which is characterized by a persistent belief in the presence of an underlying serious disease, such as cancer, despite negative test results.

Conversion disorder is another condition that involves the loss of motor or sensory function, and the patient does not consciously feign the symptoms or seek material gain. Patients with this disorder may be indifferent to their apparent disorder, a phenomenon known as la belle indifference. Dissociative disorder, on the other hand, involves the process of ‘separating off’ certain memories from normal consciousness, and may manifest as amnesia, fugue, or stupor. Dissociative identity disorder (DID) is the most severe form of dissociative disorder and was previously known as multiple personality disorder.

Factitious disorder, also known as Munchausen’s syndrome, involves the intentional production of physical or psychological symptoms. Finally, malingering is the fraudulent simulation or exaggeration of symptoms with the intention of financial or other gain. Understanding these psychiatric terms can help healthcare professionals better diagnose and treat patients with unexplained symptoms.

If the police believe that someone requires a mental health assessment or treatment, they can request a section 135 to remove the individual from their property. The procedure involves an Approved Mental Health Practitioner (AMHP) presenting evidence at a Magistrate’s Court to obtain a warrant. This warrant permits the Police, an AMHP, and a registered medical practitioner to enter the premises and conduct an assessment or take the person to a safe location for evaluation.

Sectioning under the Mental Health Act is a legal process used for individuals who refuse voluntary admission. This process excludes patients who are under the influence of drugs or alcohol. There are several sections under the Mental Health Act that allow for different types of admission and treatment.

Section 2 allows for admission for assessment for up to 28 days, which is not renewable. An Approved Mental Health Professional (AMHP) or the nearest relative (NR) can make the application on the recommendation of two doctors, one of whom should be an approved consultant psychiatrist. Treatment can be given against the patient’s wishes.

Section 3 allows for admission for treatment for up to 6 months, which can be renewed. An AMHP and two doctors, both of whom must have seen the patient within the past 24 hours, can make the application. Treatment can also be given against the patient’s wishes.

Section 4 is used as an emergency 72-hour assessment order when a section 2 would involve an unacceptable delay. A GP and an AMHP or NR can make the application, which is often changed to a section 2 upon arrival at the hospital.

Section 5(2) allows a doctor to legally detain a voluntary patient in hospital for 72 hours, while section 5(4) allows a nurse to detain a voluntary patient for 6 hours.

Section 17a allows for Supervised Community Treatment (Community Treatment Order) and can be used to recall a patient to the hospital for treatment if they do not comply with the conditions of the order in the community, such as taking medication.

Section 135 allows for a court order to be obtained to allow the police to break into a property to remove a person to a Place of Safety. Section 136 allows for someone found in a public place who appears to have a mental disorder to be taken by the police to a Place of Safety. This section can only be used for up to 24 hours while a Mental Health Act assessment is arranged.

Understanding the Side-Effects of Lithium Maintenance Therapy

Lithium maintenance therapy is a common treatment for bipolar disorder, but it can also cause a range of side-effects. One of the most common is hypothyroidism, which affects up to 5% of patients on lithium and requires regular thyroid function tests. Weight gain, acne, tremors, and polydipsia are also common, as well as ankle edema and a metallic taste in the mouth. Lithium can also cause renal toxicity, so regular urea and electrolyte tests are necessary. However, lithium does not cause abnormal liver function or fever, and actually causes leukocytosis rather than leucopenia. Cystitis is also not a typical side-effect of lithium. Overall, understanding the potential side-effects of lithium maintenance therapy is crucial for managing bipolar disorder effectively.

Selective serotonin reuptake inhibitors (SSRIs) are commonly used as the first-line treatment for depression. Citalopram and fluoxetine are the preferred SSRIs, while sertraline is recommended for patients who have had a myocardial infarction. However, caution should be exercised when prescribing SSRIs to children and adolescents. Gastrointestinal symptoms are the most common side-effect, and patients taking SSRIs are at an increased risk of gastrointestinal bleeding. Patients should also be aware of the possibility of increased anxiety and agitation after starting a SSRI. Fluoxetine and paroxetine have a higher propensity for drug interactions.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning regarding the use of citalopram due to its association with dose-dependent QT interval prolongation. As a result, citalopram and escitalopram should not be used in patients with congenital long QT syndrome, known pre-existing QT interval prolongation, or in combination with other medicines that prolong the QT interval. The maximum daily dose of citalopram is now 40 mg for adults, 20 mg for patients older than 65 years, and 20 mg for those with hepatic impairment.

When initiating antidepressant therapy, patients should be reviewed by a doctor after 2 weeks. Patients under the age of 25 years or at an increased risk of suicide should be reviewed after 1 week. If a patient responds well to antidepressant therapy, they should continue treatment for at least 6 months after remission to reduce the risk of relapse. When stopping a SSRI, the dose should be gradually reduced over a 4 week period, except for fluoxetine. Paroxetine has a higher incidence of discontinuation symptoms, including mood changes, restlessness, difficulty sleeping, unsteadiness, sweating, gastrointestinal symptoms, and paraesthesia.

When considering the use of SSRIs during pregnancy, the benefits and risks should be weighed. Use during the first trimester may increase the risk of congenital heart defects, while use during the third trimester can result in persistent pulmonary hypertension of the newborn. Paroxetine has an increased risk of congenital malformations, particularly in the first trimester.

If a person dies while under the mental health act, regardless of the cause of death, it is mandatory to report their death to the coroner. In this case, as the individual was detained under the mental health act at the time of their death, it is the responsibility of the doctors in the hospital where they passed away to issue the MCCD after discussing with the coroner. It would be inappropriate to ask the GP who performed their surgery over a year ago to issue the MCCD as they may not have seen the individual within 14 days prior to their death. Additionally, the doctors at the psychiatric hospital may have seen the individual within the 14 days prior, but it is still the responsibility of the hospital doctors who were caring for them at the time of their death to issue the MCCD.

Sectioning under the Mental Health Act is a legal process used for individuals who refuse voluntary admission. This process excludes patients who are under the influence of drugs or alcohol. There are several sections under the Mental Health Act that allow for different types of admission and treatment.

Section 2 allows for admission for assessment for up to 28 days, which is not renewable. An Approved Mental Health Professional (AMHP) or the nearest relative (NR) can make the application on the recommendation of two doctors, one of whom should be an approved consultant psychiatrist. Treatment can be given against the patient’s wishes.

Section 3 allows for admission for treatment for up to 6 months, which can be renewed. An AMHP and two doctors, both of whom must have seen the patient within the past 24 hours, can make the application. Treatment can also be given against the patient’s wishes.

Section 4 is used as an emergency 72-hour assessment order when a section 2 would involve an unacceptable delay. A GP and an AMHP or NR can make the application, which is often changed to a section 2 upon arrival at the hospital.

Section 5(2) allows a doctor to legally detain a voluntary patient in hospital for 72 hours, while section 5(4) allows a nurse to detain a voluntary patient for 6 hours.

Section 17a allows for Supervised Community Treatment (Community Treatment Order) and can be used to recall a patient to the hospital for treatment if they do not comply with the conditions of the order in the community, such as taking medication.

Section 135 allows for a court order to be obtained to allow the police to break into a property to remove a person to a Place of Safety. Section 136 allows for someone found in a public place who appears to have a mental disorder to be taken by the police to a Place of Safety. This section can only be used for up to 24 hours while a Mental Health Act assessment is arranged.

Strategies for Preventing Alcohol Relapse

For individuals with alcohol-use disorders, preventing relapse is crucial for maintaining sobriety. Here are some strategies that can help:

1. Join a local Alcoholics Anonymous group or other self-help groups that require total abstinence. Active participation in these groups can offer the best chance of preventing relapses.

2. Limit consumption to socially appropriate amounts. Even small amounts of alcohol can trigger a relapse, so individuals who have completed a detoxification program are encouraged not to drink at all.

3. Take disulfiram as prescribed. This medication can cause unpleasant symptoms when alcohol is consumed, making it a deterrent for those who struggle with alcohol use. However, it should only be taken in the context of an appropriate alcohol detoxification program.

4. Take naltrexone as prescribed. This medication can help reduce cravings for alcohol, but it should not be taken as a deterrent before attending a party.

5. Plan a definite number of drinks before attending a party. However, individuals who have completed a detoxification program are still encouraged not to drink at all to prevent relapse.

By implementing these strategies, individuals with alcohol-use disorders can increase their chances of maintaining sobriety and preventing relapse.

Olanzapine, an atypical antipsychotic, often leads to weight gain as a prevalent negative outcome.

Atypical antipsychotics are now recommended as the first-line treatment for patients with schizophrenia, as per the 2005 NICE guidelines. These medications have the advantage of significantly reducing extrapyramidal side-effects. However, they can also cause adverse effects such as weight gain, hyperprolactinaemia, and in the case of clozapine, agranulocytosis. The Medicines and Healthcare products Regulatory Agency has issued warnings about the increased risk of stroke and venous thromboembolism when antipsychotics are used in elderly patients. Examples of atypical antipsychotics include clozapine, olanzapine, risperidone, quetiapine, amisulpride, and aripiprazole.

Clozapine, one of the first atypical antipsychotics, carries a significant risk of agranulocytosis and requires full blood count monitoring during treatment. Therefore, it should only be used in patients who are resistant to other antipsychotic medication. The BNF recommends introducing clozapine if schizophrenia is not controlled despite the sequential use of two or more antipsychotic drugs, one of which should be a second-generation antipsychotic drug, each for at least 6-8 weeks. Adverse effects of clozapine include agranulocytosis, neutropaenia, reduced seizure threshold, constipation, myocarditis, and hypersalivation. Dose adjustment of clozapine may be necessary if smoking is started or stopped during treatment.

Understanding Eating Disorders: Bulimia Nervosa

Bulimia nervosa is an eating disorder that is characterized by binge eating followed by purging behaviors such as vomiting, laxative abuse, excessive exercise, and drug use. Individuals with bulimia often experience feelings of loss of control and intense guilt during binge episodes. Pitting of tooth enamel caused by stomach acid is a common sign of regular vomiting. Unlike anorexia nervosa, bulimia is not usually associated with severe weight loss. The condition is ten times more common in women. It is important to recognize the symptoms of bulimia and seek professional help for proper diagnosis and treatment.

The individual in question is exhibiting symptoms of anankastic personality disorder, also known as obsessive-compulsive personality disorder (OCPD). This disorder is characterized by a preoccupation with orderliness, perfectionism, and an excessive focus on details, as well as a need for control over one’s environment and interpersonal relationships. However, this often comes at the expense of flexibility, openness to new experiences, and efficiency. Unlike obsessive-compulsive disorder (OCD), where thoughts and behaviors are seen as unwanted and unhealthy, those with OCPD view their behaviors as rational and desirable. This can lead to difficulty completing tasks, as the individual becomes overly focused on perfectionism and attention to detail. Generalized anxiety disorder is less likely to be the diagnosis in this case, as the individual’s worries are specific to work-related issues. Schizoid personality disorder, on the other hand, is characterized by a lack of interest in forming close relationships with others and a preference for solitude. These individuals may appear cold and uninterested in intimacy or pleasure from life.

Personality disorders are a set of personality traits that are maladaptive and interfere with normal functioning in life. It is estimated that around 1 in 20 people have a personality disorder, which are typically categorized into three clusters: Cluster A, which includes Odd or Eccentric disorders such as Paranoid, Schizoid, and Schizotypal; Cluster B, which includes Dramatic, Emotional, or Erratic disorders such as Antisocial, Borderline (Emotionally Unstable), Histrionic, and Narcissistic; and Cluster C, which includes Anxious and Fearful disorders such as Obsessive-Compulsive, Avoidant, and Dependent.

Paranoid individuals exhibit hypersensitivity and an unforgiving attitude when insulted, a reluctance to confide in others, and a preoccupation with conspirational beliefs and hidden meanings. Schizoid individuals show indifference to praise and criticism, a preference for solitary activities, and emotional coldness. Schizotypal individuals exhibit odd beliefs and magical thinking, unusual perceptual disturbances, and inappropriate affect. Antisocial individuals fail to conform to social norms, deceive others, and exhibit impulsiveness, irritability, and aggressiveness. Borderline individuals exhibit unstable interpersonal relationships, impulsivity, and affective instability. Histrionic individuals exhibit inappropriate sexual seductiveness, a need to be the center of attention, and self-dramatization. Narcissistic individuals exhibit a grandiose sense of self-importance, lack of empathy, and excessive need for admiration. Obsessive-compulsive individuals are occupied with details, rules, and organization to the point of hampering completion of tasks. Avoidant individuals avoid interpersonal contact due to fears of criticism or rejection, while dependent individuals have difficulty making decisions without excessive reassurance from others.

Personality disorders are difficult to treat, but a number of approaches have been shown to help patients, including psychological therapies such as dialectical behavior therapy and treatment of any coexisting psychiatric conditions.

Understanding Abnormal and Normal Grief Reactions

Grief is a highly individualized experience that can be influenced by personal, social, and cultural factors. There are three recognized types of abnormal grief reactions: delayed, inhibited, and prolonged. Delayed grief is characterized by a delay of more than two weeks before grieving begins, or sometimes not occurring at all until triggered by another subsequent bereavement. Inhibited grief occurs when the bereaved person appears minimally affected by the death, and prolonged grief lasts significantly longer than average.

On the other hand, normal grief reactions are characterized by features such as sadness, weeping, poor sleep, reduced appetite, motor restlessness, searching for the deceased, poor concentration and memory, low mood (but not frank depression), and the impression of seeing or hearing the deceased. Poor memory, brief episodes of seeing the dead person, poor concentration, and searching for the deceased are all common manifestations of a normal grief reaction.

It is important to note that there is a great degree of flexibility when assessing whether a grief reaction is normal or abnormal, as it is a highly personal experience. Understanding the different types of grief reactions can help individuals and their loved ones navigate the grieving process and seek appropriate support.

Differentiating Hypochondriasis from Other Disorders

Hypochondriasis is a condition characterized by persistent preoccupation with having a serious physical illness. However, it is important to differentiate it from other disorders with similar symptoms.

Conversion disorder is a neurological condition that presents with loss of function without an organic cause. Delusional disorder-somatic type involves delusional thoughts about having a particular illness or physical problem. In somatisation disorder, patients present with medically unexplained symptoms and seek medical attention to find an explanation for them. Factitious disorder involves deliberately producing symptoms for attention as a patient.

It is important to note that in hypochondriasis, the patient’s beliefs are not as fixed as they would be in delusional disorder-somatic type, and worry dominates the picture. In somatisation disorder, the emphasis is on the symptoms rather than a specific diagnosis, while in hypochondriasis, the patient puts emphasis on the presence of a specific illness. Factitious disorder involves deliberate production of symptoms, which is not present in hypochondriasis.

Understanding Different Types of Dementia

Dementia is a common condition that affects a significant portion of the elderly population. Alzheimer’s disease is the most common type of dementia, accounting for over 60% of cases. It typically starts with memory impairment, particularly affecting recent events, and gradually progresses to language and visuospatial dysfunction, apathy, and behavioural problems.

Vascular dementia is the second most common type of dementia, and it is often associated with a history of cerebrovascular or cardiovascular disease. Depression can also cause memory impairment and apathy, but the characteristic pattern of memory disturbance seen in Alzheimer’s disease makes it a more likely diagnosis in this case.

Mild cognitive impairment is a condition where memory impairment is present, but other cognitive domains and activities of daily living are preserved. It is estimated that between 5 and 20% of people over 65 have MCI, and about 30% of them will develop dementia within two years.

Lewy-body dementia is another type of dementia that accounts for about 20% of cases. It typically presents with parkinsonism, fluctuating cognitive impairment, and visual hallucinations, which are not present in this vignette.

Understanding the different types of dementia and their characteristic features is important for accurate diagnosis and appropriate management.

Lorazepam is a benzodiazepine drug that can cause anterograde amnesia as a side effect, resulting in significant impairment of memory recall and the formation of new memories. Additionally, it is utilized in anesthesia.

Benzodiazepines are drugs that enhance the effect of the neurotransmitter GABA, which inhibits brain activity. They are used for various purposes, including sedation, anxiety relief, muscle relaxation, and seizure prevention. However, patients can develop a tolerance and dependence on these drugs, so they should only be prescribed for a short period of time. When withdrawing from benzodiazepines, it is important to do so gradually to avoid withdrawal symptoms, which can include insomnia, anxiety, and seizures. Barbiturates are another type of drug that affect GABA, but they work differently than benzodiazepines by increasing the duration of chloride channel opening.

In cases where there is a need for urgent psychiatric assessment, GPs may utilize Section 4 of the Mental Health Act. This can be done with the assistance of an AMHP or NR, and allows for the emergency transfer of the patient. Unlike Section 2, which requires the agreement of two psychiatrists, Section 4 is used when there is a risk of unacceptable delay in the patient’s care. It provides a 72-hour window for assessment, after which it is typically converted to a Section 2. Additionally, the police have the authority under Section 135 and 136 to take a patient to a safe location for psychiatric evaluation.

Sectioning under the Mental Health Act is a legal process used for individuals who refuse voluntary admission. This process excludes patients who are under the influence of drugs or alcohol. There are several sections under the Mental Health Act that allow for different types of admission and treatment.

Section 2 allows for admission for assessment for up to 28 days, which is not renewable. An Approved Mental Health Professional (AMHP) or the nearest relative (NR) can make the application on the recommendation of two doctors, one of whom should be an approved consultant psychiatrist. Treatment can be given against the patient’s wishes.

Section 3 allows for admission for treatment for up to 6 months, which can be renewed. An AMHP and two doctors, both of whom must have seen the patient within the past 24 hours, can make the application. Treatment can also be given against the patient’s wishes.

Section 4 is used as an emergency 72-hour assessment order when a section 2 would involve an unacceptable delay. A GP and an AMHP or NR can make the application, which is often changed to a section 2 upon arrival at the hospital.

Section 5(2) allows a doctor to legally detain a voluntary patient in hospital for 72 hours, while section 5(4) allows a nurse to detain a voluntary patient for 6 hours.

Section 17a allows for Supervised Community Treatment (Community Treatment Order) and can be used to recall a patient to the hospital for treatment if they do not comply with the conditions of the order in the community, such as taking medication.

Section 135 allows for a court order to be obtained to allow the police to break into a property to remove a person to a Place of Safety. Section 136 allows for someone found in a public place who appears to have a mental disorder to be taken by the police to a Place of Safety. This section can only be used for up to 24 hours while a Mental Health Act assessment is arranged.

Conversion disorder is a condition that often results in the loss of motor or sensory function and is believed to be triggered by stress.

Psychiatric Terms for Unexplained Symptoms

There are various psychiatric terms used to describe patients who exhibit symptoms for which no organic cause can be found. One such disorder is somatisation disorder, which involves the presence of multiple physical symptoms for at least two years, and the patient’s refusal to accept reassurance or negative test results. Another disorder is illness anxiety disorder, which is characterized by a persistent belief in the presence of an underlying serious disease, such as cancer, despite negative test results.

Conversion disorder is another condition that involves the loss of motor or sensory function, and the patient does not consciously feign the symptoms or seek material gain. Patients with this disorder may be indifferent to their apparent disorder, a phenomenon known as la belle indifference. Dissociative disorder, on the other hand, involves the process of ‘separating off’ certain memories from normal consciousness, and may manifest as amnesia, fugue, or stupor. Dissociative identity disorder (DID) is the most severe form of dissociative disorder and was previously known as multiple personality disorder.

Factitious disorder, also known as Munchausen’s syndrome, involves the intentional production of physical or psychological symptoms. Finally, malingering is the fraudulent simulation or exaggeration of symptoms with the intention of financial or other gain. Understanding these psychiatric terms can help healthcare professionals better diagnose and treat patients with unexplained symptoms.

Differentiating Seasonal Affective Disorder from Other Depressive Disorders

Seasonal affective disorder (SAD) is a type of depression that occurs in a regular temporal pattern, typically beginning in autumn or winter and ending in spring or summer. Unlike classic major depression, SAD is characterized by symptoms of hyperphagia, hypersomnia, and weight gain. The cause of SAD is believed to be a malfunction of the light-sensitive hormone melatonin during winter. Treatment involves phototherapy, which exposes individuals to bright light for several hours a day.

Reactive depression, on the other hand, is a subtype of major depression that occurs as a result of an external event, such as a relationship breakdown or bereavement. There is no indication of a stressful life event in the presented vignette.

Bipolar affective disorder is characterized by distinct episodes of depression and mania, which is not evident in the vignette. Dysthymia is a persistent depression of mood that does not fully meet the criteria for a diagnosis of major depression and does not have a definite seasonal variation like SAD.

Finally, double depression occurs when one or more episodes of major depression occur on a background of dysthymia. It is important to differentiate SAD from other depressive disorders to provide appropriate treatment and management.

Understanding the Risk Factors for Suicide

Suicide is a complex issue with a variety of risk factors. The strongest indicators of suicide are the presence of a mental disorder, including alcohol-use disorder, and a history of previous suicide attempts. Age and sex also play a role, with the risk increasing with age and men being more likely to complete suicide. Marital status, unemployment, living alone, and chronic illnesses are also associated with an increased risk. It is important to understand these risk factors in order to identify and prevent suicide.

Procyclidine is the usual treatment for acute dystonia caused by antipsychotics. This patient’s acute dystonic reaction can be reversed with procyclidine, which is an anticholinergic medication that blocks acetylcholine. This medication can alleviate muscle stiffness, sweating, and excessive saliva production, and can also improve walking ability in individuals with Parkinson’s disease. The patient most likely developed this reaction due to long-term use of antipsychotics and subsequent administration of metoclopramide. While midazolam and lorazepam can relieve anxiety, they are not effective in treating dystonia.

Antipsychotics are a group of drugs used to treat schizophrenia, psychosis, mania, and agitation. They are divided into two categories: typical and atypical antipsychotics. The latter were developed to address the extrapyramidal side-effects associated with the first generation of typical antipsychotics. Typical antipsychotics work by blocking dopaminergic transmission in the mesolimbic pathways through dopamine D2 receptor antagonism. They are associated with extrapyramidal side-effects and hyperprolactinaemia, which are less common with atypical antipsychotics.

Extrapyramidal side-effects (EPSEs) are common with typical antipsychotics and include Parkinsonism, acute dystonia, sustained muscle contraction, akathisia, and tardive dyskinesia. The latter is a late onset of choreoathetoid movements that may be irreversible and occur in 40% of patients. The Medicines and Healthcare products Regulatory Agency has issued specific warnings when antipsychotics are used in elderly patients, including an increased risk of stroke and venous thromboembolism. Other side-effects include antimuscarinic effects, sedation, weight gain, raised prolactin, impaired glucose tolerance, neuroleptic malignant syndrome, reduced seizure threshold, and prolonged QT interval.

Discontinuation syndrome, characterized by dizziness, electric shock sensations, and anxiety, is a common occurrence when SSRIs are abruptly stopped. This is why it is recommended to gradually taper off the medication. The patient in this scenario stopped their medication abruptly due to a suspected neurological event, leading to the onset of discontinuation syndrome. Atorvastatin, bisoprolol, and gabapentin are not typically associated with these symptoms when stopped abruptly.

Selective serotonin reuptake inhibitors (SSRIs) are commonly used as the first-line treatment for depression. Citalopram and fluoxetine are the preferred SSRIs, while sertraline is recommended for patients who have had a myocardial infarction. However, caution should be exercised when prescribing SSRIs to children and adolescents. Gastrointestinal symptoms are the most common side-effect, and patients taking SSRIs are at an increased risk of gastrointestinal bleeding. Patients should also be aware of the possibility of increased anxiety and agitation after starting a SSRI. Fluoxetine and paroxetine have a higher propensity for drug interactions.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning regarding the use of citalopram due to its association with dose-dependent QT interval prolongation. As a result, citalopram and escitalopram should not be used in patients with congenital long QT syndrome, known pre-existing QT interval prolongation, or in combination with other medicines that prolong the QT interval. The maximum daily dose of citalopram is now 40 mg for adults, 20 mg for patients older than 65 years, and 20 mg for those with hepatic impairment.

When initiating antidepressant therapy, patients should be reviewed by a doctor after 2 weeks. Patients under the age of 25 years or at an increased risk of suicide should be reviewed after 1 week. If a patient responds well to antidepressant therapy, they should continue treatment for at least 6 months after remission to reduce the risk of relapse. When stopping a SSRI, the dose should be gradually reduced over a 4 week period, except for fluoxetine. Paroxetine has a higher incidence of discontinuation symptoms, including mood changes, restlessness, difficulty sleeping, unsteadiness, sweating, gastrointestinal symptoms, and paraesthesia.

When considering the use of SSRIs during pregnancy, the benefits and risks should be weighed. Use during the first trimester may increase the risk of congenital heart defects, while use during the third trimester can result in persistent pulmonary hypertension of the newborn. Paroxetine has an increased risk of congenital malformations, particularly in the first trimester.